Cost effectiveness of monitoring warfarin therapy using standard versus capillary prothrombin times

American Journal of Clinical Pathology
Jack E AnsellN Knapic

Abstract

The authors assessed the cost effectiveness of monitoring warfarin therapy guided by standard plasma prothrombin times performed on blood samples obtained by venipuncture versus prothrombin times performed on capillary whole blood samples obtained by fingerstick. Twenty patients receiving long-term oral anticoagulation had either standard or capillary prothrombin times determined every other week for eight weeks in a cross-over design. All time intervals were monitored, including receptionist, secretarial, nursing, phlebotomy, etc., and costs for all materials, procedures, and labor were calculated. The total cost per test by the capillary whole blood prothrombin time method was significantly less than by standard prothrombin time methods ($7.55 vs. $15.64) even though the nurse-patient encounter time was greater per test for the capillary method (12.4 minutes vs. 8.3 minutes). The management of oral anticoagulation guided by prothrombin times performed on instrumentation designed to sample capillary whole blood should result in a significant cost savings, and because of the immediate availability of results, provide the potential for improved health care.

Citations

Feb 23, 2000·Journal of Cardiovascular Pharmacology and Therapeutics·M D EzekowitzN Redmond
Nov 17, 2005·The Annals of Pharmacotherapy·Nayahmka J McGriff-LeeUNKNOWN Anticoagulation Working Group
Jan 13, 2000·Journal of General Internal Medicine·J E LafataR E Ward
Sep 10, 2003·The American Journal of Geriatric Cardiology·Dorothy S CheungBrian F Gage
Sep 24, 2009·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Daniel E JonasMichael Pignone

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.